Showing 1,659 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

2014 UK Consensus Guidelines — Hepatitis C Management and Direct-acting Anti-viral Therapy

Editor's pick
Medscape (requires registration)
19 June 2014
New & experimental hepatitis C treatment

UNITED STATES: FDA Approves AbbVie's Hepatitis C Regimen for Priority Review

Editor's pick
CDC
19 June 2014
New & experimental hepatitis C treatment

AbbVie all-oral hepatitis C therapy gets rapid EU review

Editor's pick
Reuters
17 June 2014
Hepatitis C treatment

NICE rejection looms for Sovaldi

Editor's pick
Pharmafile
16 June 2014
New & experimental hepatitis C treatment

NICE consults on draft guidance on the drug sofosbuvir (Sovaldi) for treating hepatitis C

Editor's pick
NICE press release
16 June 2014
Pharmaceutical industry

FDA lifts hold on Achillion's hepatitis C drug, shares jump

Editor's pick
Reuters
11 June 2014
Hepatitis C treatment

Why The Hepatitis C Cost Cutters May Have Already Lost

Editor's pick
Forbes
11 June 2014
Hepatitis C treatment

Why is the $1,000 pill cheaper in the UK?

Editor's pick
Columbia Journalism Review
10 June 2014
Hepatitis C symptoms & diagnosis

Project Inform disappointed with direction of California hepatitis C testing bill

Editor's pick
Project Inform
10 June 2014
Hepatitis C treatment

England: New study reveals the costs of low uptake of hepatitis C treatment

Editor's pick
Public Health England (press release)
10 June 2014
New & experimental hepatitis C treatment

Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C

Editor's pick
Forbes
9 June 2014
Hepatitis C symptoms & diagnosis

Medicare Will Cover Hepatitis C Screening in Primary Care Settings

Editor's pick
aids.gov
9 June 2014
Access to healthcare

Hepatitis Warrior Hiking in China Shows Glaxo Hurdles

Editor's pick
Bloomberg
30 May 2014
New & experimental hepatitis C treatment

No critical interactions between ledipasvirsofosbuvir and certain key antiretrovirals

Editor's pick
NATAP
29 May 2014
Access to healthcare

WHA Adopts Resolution On Hepatitis; Member States Concerned Over High Prices

Editor's pick
Intellectual Property Watch
23 May 2014
Hepatitis C treatment

Today new hepatitis resolution is passed at world health assembly; challenges World Health Organization and member states to act

Editor's pick
Treatment Action Group
23 May 2014
Hepatitis C treatment

Defuse Hepatitis C, the Viral Time Bomb: Test and Treat Hepatitis C

Editor's pick
Treatment Action Group
21 May 2014
Hepatitis C treatment

US health insurers say Gilead hepatitis C drug too costly

Editor's pick
Reuters
21 May 2014
New & experimental hepatitis C treatment

OLYSIO™ (simeprevir) receives marketing authorisation in the European Union for the treatment of adults with hepatitis C genotype 1 and 4 infection

Editor's pick
Reuters
16 May 2014
Prisoners

To curb hepatitis C, test and treat inmates

Editor's pick
Eurekalert Inf Dis
15 May 2014
New & experimental hepatitis C treatment

AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C

Editor's pick
AbbVie press release
8 May 2014
Hepatitis C treatment

ITPCru report: Access to drugs for treating hepatitis C in Russia in 2013

Editor's pick
EATG
8 May 2014
Hepatitis C treatment

Janssen submits US FDA new drug application for simeprevir / sofosbuvir combination use

Editor's pick
Janssen press release
8 May 2014
Access to healthcare

UNITAID approves grants of $160 million, for hepatitis C, MDR-TB and malaria drugs

Editor's pick
UNITAID
7 May 2014